Premium
SANUWAVE Health Inc (QB) (SNWV)
USOTC
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE's portfolio of products and product cand... SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE's portfolio of products and product candidates activate biologic signaling and angiogenic responses, including revascularization and microcirculatory improvement, helping restore the body's normal healing processes and regeneration. SANUWAVE is applying its Pulsed Acoustic Cellular Expression (PACE) technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions. Show more
SANUWAVE is pleased to announce preliminary revenues of $10.1 million to $10.3 million for the fourth quarter ended December 31, 2024. This represents the highest quarterly revenues in...
Wern Brings Strong Team Building, Growth, and Sales Skills to SANUWAVE After a Career of Growing Start Ups Into Mid and Large Sized Companies EDEN PRAIRIE, MN -- January 13, 2025...
Q3 2024 revenues were $9.4 million, up 89% from Q3 2023. This was an all-time quarterly record for the Company. Q3 2024 gross margin was 75.5%, vs 71.5% in Q3 2023 GAAP Operating...
1-for-375 reverse stock split effective at market open today Exchanged $43.2 million in principal amount of convertible notes and warrants previously exercisable for approximately 1.7 billion...
Common Stock Will Begin Trading on a Split-adjusted Basis on October 18, 2024EDEN PRAIRIE, MN -- October 16, 2024 -- InvestorsHub NewsWire -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE...
Q2 2024 revenues were $7.2 million, up 53% from Q2 2023. This was an all-time quarterly record for the Company. Q2 2024 Gross Margin was 73%, vs 74% in Q2 2023 GAAP Operating Income was $2.0...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.32 | 1.18606375093 | 26.98 | 28.2 | 25.13 | 5629 | 26.86842498 | CS |
| 4 | 4.3 | 18.6956521739 | 23 | 29 | 20.5 | 11254 | 25.33426026 | CS |
| 12 | 3.8 | 16.170212766 | 23.5 | 29 | 18.502 | 10688 | 23.22227513 | CS |
| 26 | 20.7375 | 316 | 6.5625 | 29 | 5.175 | 386178 | 9.01417305 | CS |
| 52 | 19.05 | 230.909090909 | 8.25 | 29 | 4.275 | 352512 | 8.40975119 | CS |
| 156 | -28.95 | -51.4666666667 | 56.25 | 70.125 | 0.0375 | 359879 | 11.86833808 | CS |
| 260 | -34.575 | -55.8787878788 | 61.875 | 119.625 | 0.0375 | 342475 | 35.83225273 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
